Science Explorer Back to mapMap

Most cited papers from Strategic Solutions Consulting (United States)

Strategic Solutions Consulting (United States)

What are the most cited papers from Strategic Solutions Consulting (United States)?

The most cited paper from Strategic Solutions Consulting (United States) is "Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults?" (Peggy Mannen Cawthon, Kathleen M. Fox, Shravanthi R. Gandra et al., 2009), with 419 citations. Next come "Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications" (355) and "Predicting Accuracy of Early Cost Estimates Using Factor Analysis and Multivariate Regression" (291).

Showing 50 of 60 papers. Every paper with more than 28 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Do Muscle Mass, Muscle Density, Strength, and Physical Function Similarly Influence Risk of Hospitalization in Older Adults? Peggy Mannen Cawthon, Kathleen M. Fox, Shravanthi R. Gandra et al. · Journal of the American Geriatrics Society Open access 29 Jul 2009 419
2 Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications Katherine H. Luepke, Katie J. Suda, Helen W. Boucher et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy Open access 14 Nov 2016 355
3 Predicting Accuracy of Early Cost Estimates Using Factor Analysis and Multivariate Regression Steven M. Trost, Garold D. Oberlender · Journal of Construction Engineering and Management 21 Mar 2003 291
4 Linking Futures across Scales: a Dialog on Multiscale Scenarios Reinette Biggs, Ciara Raudsepp‐Hearne, Carol Atkinson‐Palombo et al. · Ecology and Society Open access 2007 220
5 Chronic wound prevalence and the associated cost of treatment in Medicare beneficiaries: changes between 2014 and 2019 Marissa Janine Carter, Joan DaVanzo, Randall Haught et al. · Journal of Medical Economics Open access 7 Jul 2023 167
6 The Future of Enterprise System-Enabled Organizations Thomas H. Davenport · Information Systems Frontiers Aug 2000 162
7 Tiered Approach to Resilience Assessment Igor Linkov et al. · Risk Analysis Open access 25 Apr 2018 147
8 Association of patient-reported psoriasis severity with income and employment Elizabeth J. Horn, Kathleen M. Fox, Vaishali D. Patel et al. · Journal of the American Academy of Dermatology 30 Aug 2007 145
9 Estimation of Cachexia among Cancer Patients Based on Four Definitions Kathleen M. Fox, John M. Brooks, Shravanthi R. Gandra et al. · Journal of Oncology Open access 2009 145
10 Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: A series of retrospective analyses of data from 1998 through 2002 Kathleen M. Fox, Robert A. Gerber, Björn Bolinder et al. · Clinical Therapeutics Mar 2006 143
11 The lenses of lean: Visioning the science and practice of efficiency Wallace J. Hopp, Mark S. Spearman · Journal of Operations Management Open access 21 Sep 2020 139
12 Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study Hyungtae Kim, Siin Kim, Sola Han et al. · BMC Public Health Open access 14 Aug 2019 137
13 Publicly Reported Wound Healing Rates: The Fantasy and the Reality Caroline E. Fife, Kristen Allison Eckert, Marissa Janine Carter · Advances in Wound Care Open access 28 Sep 2017 135
14 Cheating in the age of generative AI: A high school survey study of cheating behaviors before and after the release of ChatGPT Victor R. Lee, Denise Clark Pope, Sarah Miles et al. · Computers and Education Artificial Intelligence Open access 13 Jun 2024 128
15 Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus Andrew Green, Kathleen M. Fox, Susan Grandy · Diabetes Research and Clinical Practice 31 Jan 2012 116
16 Reimagining the language of engagement in a post-stakeholder world Mark S. Reed et al. · Sustainability Science Open access 29 Apr 2024 115
17 EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) Susan Grandy, Kathleen M. Fox · Health and Quality of Life Outcomes Open access 2008 98
18 Quality of life and depression of people living with type 2 diabetes mellitus and those at low and high risk for type 2 diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD) Susan Grandy, Richard H. Chapman, Kathleen M. Fox et al. · International Journal of Clinical Practice Open access 8 Feb 2008 96
19 Industrial marketing strategy Dennis J. Dolan · Industrial Marketing Management Aug 1985 92
20 Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings Machaon Bonafede, Kathleen M. Fox, Crystal Watson et al. · Advances in Therapy Open access Aug 2012 91
21 Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda Reuben Kiggundu, Rachel Wittenauer, JP Waswa et al. · Antibiotics Open access 4 Feb 2022 90
22 Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins Kathleen M. Fox, Ming‐Hui Tai, Karel Kostev et al. · Clinical Research in Cardiology Open access 22 Dec 2017 86
23 Clustering of Strength, Physical Function, Muscle, and Adiposity Characteristics and Risk of Disability in Older Adults Peggy Mannen Cawthon, Kathleen M. Fox, Shravanthi R. Gandra et al. · Journal of the American Geriatrics Society Open access May 2011 83
24 Change in health status (EQ-5D) over 5 years among individuals with and without type 2 diabetes mellitus in the SHIELD longitudinal study Susan Grandy, Kathleen M. Fox, the SHIELD Study Group · Health and Quality of Life Outcomes Open access 2012 81
25 Prevalence of self-reported diagnosis of diabetes mellitus and associated risk factors in a national survey in the US population: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes) Harold Edward Bays, Debbra D. Bazata, Nathaniel G. Clark et al. · BMC Public Health Open access 3 Oct 2007 76
26 An Update on the Appropriate Role for Hyperbaric Oxygen: Indications and Evidence Caroline E. Fife, Kristen Allison Eckert, Marissa Janine Carter · Plastic & Reconstructive Surgery Open access 23 Aug 2016 71
27 Burden of hereditary transthyretin amyloidosis on quality of life Aaron S. Yarlas, Morie Abraham Gertz, Noel Rakhi Dasgupta et al. · Muscle & Nerve Open access 16 May 2019 64
28 Cost per Treated Patient for Etanercept, Adalimumab, and Infliximab Across Adult Indications: a Claims Analysis Machaon Bonafede, Shravanthi R. Gandra, Crystal Watson et al. · Advances in Therapy Mar 2012 59
29 Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study Kathleen M. Fox, Li Wang, Shravanthi R. Gandra et al. · BMC Cardiovascular Disorders Open access 14 Jan 2016 57
30 Efficacy of Topical Wound Oxygen Therapy in Healing Chronic Diabetic Foot Ulcers: Systematic Review and Meta-Analysis Marissa Janine Carter, Robert G. Frykberg, Alisha Oropallo et al. · Advances in Wound Care ReviewOpen access 20 May 2022 54
31 Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD Sandra J. Lewis, Helena W. Rodbard, Kathleen M. Fox et al. · International Journal of Clinical Practice Open access 29 Apr 2008 54
32 Annual costs of tumor necrosis factor inhibitors using real-world data in a commercially insured population in the United States Vernon F. Schabert, Crystal Watson, Shravanthi R. Gandra et al. · Journal of Medical Economics Open access 28 Nov 2011 49
33 Health-related behaviours of people with diabetes and those with cardiometabolic risk factors: results from SHIELD A. J. Green, Debbra D. Bazata, Kathleen M. Fox et al. · International Journal of Clinical Practice Open access 20 Sep 2007 49
34 From Empower to Green Dot Patricia G. Cook-Craig, Phyllis H. Millspaugh, Eileen A. Recktenwald et al. · Violence Against Women 25 Sep 2014 48
35 Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials Nicole Sheetz, Brett Wilson, Joanne Benedict et al. · Therapeutic Innovation & Regulatory Science Open access 10 Oct 2014 48
36 Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting Machaon Bonafede, Barbara H. Johnson, Kathleen M. Fox et al. · Journal of Dermatological Treatment Open access 26 Feb 2013 47
37 Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women Oth Tran, Stuart L. Silverman, Xiaoqing Xu et al. · Osteoporosis International Open access 7 Jan 2021 46
38 Race/Ethnicity and gender differences in health intentions and behaviors regarding exercise and diet for adults with type 2 diabetes: A cross-sectional analysis James R. Gavin, Kathleen M. Fox, Susan Grandy · BMC Public Health Open access 5 Jul 2011 46
39 A multi‐centre, single‐blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers David G. Armstrong, Dennis Paul Orgill, Robert D. Galiano et al. · International Wound Journal Open access 21 Aug 2021 45
40 Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists Vaishali D. Patel, Elizabeth J. Horn, Steve Lobosco et al. · Journal of the American Academy of Dermatology 19 Apr 2008 45
41 Affecting Behavior Change in Individuals With Diabetes Findings From the Study to Help Improve Early Evaluation and Management of Risk Factors Leading to Diabetes (SHIELD) Debbra D. Bazata, Jennifer G. Robinson, Kathleen M. Fox et al. · The Science of Diabetes Self-Management and Care Nov 2008 45
42 Comparative Safety of Long-Acting Inhaled Bronchodilators Michele Jara, Stephan Lanes, Charles E. Wentworth et al. · Drug Safety 2007 45
43 Atherosclerosis profile and incidence of cardiovascular events: a population-based survey Jennifer G. Robinson, Kathleen M. Fox, Michael F. Bullano et al. · BMC Cardiovascular Disorders Open access 15 Sep 2009 42
44 Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia Rajeshwari S. Punekar, Kathleen M. Fox, Akshara Richhariya et al. · Clinical Cardiology Open access 23 Jun 2015 40
45 Impact of Regular Exercise and Attempted Weight Loss on Quality of Life among Adults with and without Type 2 Diabetes Mellitus Andrew Green, Kathleen M. Fox, Susan Grandy · Journal of Obesity Open access 23 Sep 2010 39
46 Impact of type 2 diabetes mellitus on prescription medication burden and out-of-pocket healthcare expenses Helena W. Rodbard, Andrew Green, Kathleen M. Fox et al. · Diabetes Research and Clinical Practice 5 Jan 2010 39
47 A mixed methods assessment of barriers to maternal, newborn and child health in Gogrial West, South Sudan Lynn Lieberman Lawry, Covadonga Canteli, Tahina Rabenzanahary et al. · Reproductive Health Open access 19 Jan 2017 37
48 Perceived body image in men and women with type 2 diabetes mellitus: correlation of body mass index with the figure rating scale Harold Edward Bays, Debbra D. Bazata, Kathleen M. Fox et al. · Nutrition Journal Open access Dec 2009 35
49 Cognitive processes in program comprehension: An empirical analysis in the Context of software reengineering Vairam Arunachalam, William C. Sasso · Journal of Systems and Software Sep 1996 35
50 Metastatic non-small cell lung cancer: costs associated with disease progression. Kathleen M. Fox, John M. Brooks, Jennifer Kim · PubMed Sep 2008 34

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.